Vitamin A for preventing secondary infections in children with measles--a systematic review

Rennie M D'Souza1, Ron D'Souza

  • 1National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia. rennie.dsouza@anu.edu.au

Insights

Vitamin A supplementation significantly reduced croup and otitis media incidence in children with measles. It also decreased the duration of diarrhea, pneumonia, and fever, indicating a beneficial effect on measles-related morbidity.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Nutritional Science

Background:

  • Measles is a significant cause of childhood morbidity and mortality globally.
  • Vitamin A deficiency is common in children with measles, exacerbating disease severity.
  • Previous studies suggest a potential role for vitamin A in managing measles complications.

Purpose of the Study:

  • To evaluate the efficacy of vitamin A supplementation in preventing and treating infections in children with measles.
  • To assess the impact of vitamin A on the incidence and duration of specific measles-related complications.

Main Methods:

  • A meta-analysis of randomized controlled trials was conducted.
  • Systematic literature search identified six relevant trials involving 492 children supplemented with vitamin A and 536 controls.
  • Outcomes included incidence and duration of pneumonia, diarrhea, croup, otitis media, fever, and hospitalization.

Main Results:

  • Vitamin A supplementation showed a 47% reduction in croup incidence and a 74% reduction in otitis media incidence.
  • No significant reduction in pneumonia or diarrhea incidence was observed.
  • Statistically significant decreases in the duration of diarrhea, pneumonia, fever, and hospitalization were noted.

Conclusions:

  • Vitamin A treatment demonstrates a beneficial effect on measles-related morbidity.
  • Supplementation is recommended for hospitalized measles cases to reduce complication severity and duration.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.